Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
Boehringer Ingelheim
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
MedImmune LLC
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Centre Leon Berard
Columbia University
AstraZeneca
Istituto Oncologico Veneto IRCCS
Institut Curie
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
Institut Curie
Gilead Sciences
Klus Pharma Inc.
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GERCOR - Multidisciplinary Oncology Cooperative Group
University of Chicago
SOLTI Breast Cancer Research Group
Merck Sharp & Dohme LLC
University Health Network, Toronto
The Netherlands Cancer Institute
Yancheng First People's Hospital
Uppsala University Hospital
Vanderbilt-Ingram Cancer Center
University Medical Center Groningen
Sun Yat-sen University
The Hospital for Sick Children
St. Jude Children's Research Hospital
Oslo University Hospital
Idera Pharmaceuticals, Inc.